Concepedia

Michele Mascia

MM

Statistics

Publications

3

Citations

84

H-Index

3

Active since

2002

Affiliations

SIB Swiss Institute of Bioinformatics(Current)

Università della Svizzera italiana

Institute of Oncology Research

Michele Mascia is an author at SIB Swiss Institute of Bioinformatics specializing in pharmacology, oncology, and bruton's tyrosine kinase inhibitors.

Publications per year

2002–2023

3

Publications

3

Short Communication: A Comparison of the Biologic Activity of Two Recombinant IFN- <i>β</i> Preparations Used in the Treatment of Relapsing-Remitting Multiple Sclerosis

F Antonetti, Ornella Finocchiaro, Michele Mascia et al. · Journal of Interferon & Cytokine Research · 2002 · 47 citations

, , +11

The <scp>ATR</scp> inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the <scp>PI3K</scp> inhibitor copanlisib

Giulio Sartori, Chiara Tarantelli, Filippo Spriano et al. · British Journal of Haematology · 2023 · 19 citations

, , +16

Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas

Filippo Spriano, Chiara Tarantelli, Eugenio Gaudio et al. · British Journal of Haematology · 2019 · 18 citations · Full text

, , +14

1–3 of 3